Cline Scientific receives Decision to Grant for StemCART in Europe

Cline Scientific has received a Decision to Grant from the European Patent Office (EPO) related to the StemCART patent.

The patent application is titled "A method for providing a cartilage implant with chondrocytes". The decision will take effect from the 14th of June 2023.

The notice of allowance for this patent was received from EPO and a press release was sent out in April.

More about StemCART

StemCART is a preclinical Advanced Therapy Medicinal Product (ATMP) that aims to revolutionize the treatment of cartilage damage for patients worldwide.

For more information, please contact:

Hanne Evenbratt, Interim CEO and VP – Research & Development

Email: [email protected]

Phone: +46 704 88 79 23